Literature DB >> 30277879

Type 1 diabetes.

Richard Barnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30277879     DOI： 10.1016/S0140-6736(18)30024-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

Review 1.  Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer.

Authors:  Xiaojia Li; Jie He; Keping Xie
Journal:  Cell Oncol (Dordr)       Date:  2022-03-15       Impact factor: 6.730

2.  Transcriptome analysis of peripheral blood mononuclear cells in patients with type 1 diabetes mellitus.

Authors:  Zhaoxiang Wang; Li Zhang; Fengyan Tang; Zhongming Yang; Mengzhu Wang; Jue Jia; Dong Wang; Ling Yang; Shao Zhong; Guoyue Yuan
Journal:  Endocrine       Date:  2022-08-17       Impact factor: 3.925

Review 3.  Evidence and possible mechanisms of probiotics in the management of type 1 diabetes mellitus.

Authors:  Kodzovi Sylvain Dovi; Ousman Bajinka; Ishmail Conteh
Journal:  J Diabetes Metab Disord       Date:  2022-02-24

Review 4.  The need for "gentle medicine" in a post Covid-19 world.

Authors:  Gabriel Andrade; Maria Campo Redondo
Journal:  Med Health Care Philos       Date:  2021-08-20

5.  Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.

Authors:  Angela Lombardi; Erlinda Concepcion; Hanxi Hou; Hanane Arib; Mihaly Mezei; Roman Osman; Yaron Tomer
Journal:  J Autoimmun       Date:  2020-09-17       Impact factor: 7.094

Review 6.  The Role of Regulatory B cells in Kidney Diseases.

Authors:  Wang Long; Hedong Zhang; Wenjia Yuan; Gongbin Lan; Zhi Lin; Longkai Peng; Helong Dai
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

7.  Signature RNAS and related regulatory roles in type 1 diabetes mellitus based on competing endogenous RNA regulatory network analysis.

Authors:  Qinghong Shi; Hanxin Yao
Journal:  BMC Med Genomics       Date:  2021-05-18       Impact factor: 3.063

8.  Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes.

Authors:  Qing Ling; Lei Shen; Wei Zhang; DuoDuo Qu; Hongdong Wang; Bin Wang; Yong Liu; Jing Lu; Dalong Zhu; Yan Bi
Journal:  Mol Med       Date:  2022-02-05       Impact factor: 6.354

9.  Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial.

Authors:  Benjamin Udoka Nwosu; Sadichchha Parajuli; Gabrielle Jasmin; Jody Fleshman; Rohit B Sharma; Laura C Alonso; Austin F Lee; Bruce A Barton
Journal:  J Endocr Soc       Date:  2021-11-26

10.  An Exploratory Study of Itolizumab on the Preservation of Beta Cell Function in Adults with Recent-Onset Type 1 Diabetes.

Authors:  Eduardo Cabrera-Rode; Ileana Cubas-Dueñas; Janet Rodríguez-Acosta; Yudith García-García; Yelena Torres-López; Claudia Prieto-Noa; Bárbara M Vázquez-Izada; Maité Ruíz-Reinoso; Ragmila Echevarría-Valdés; Aimee Álvarez-Álvarez; Emma Domínguez-Alonso; Ana Ibis Conesa-González; Teresa González-Calero; Erick Robles-Torres; Silvia Elena Turcios-Tristá; Elizabeth Senra-Estévez; Patricia Hernández-Casaña; Luis Sarmiento
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.